Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of DS-8500a in patients with Type 2 Diabetes Mellitus
jRCT2080222546Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of firuglipel in type 2 diabetes mellitus (T2DM), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
firuglipel
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080222546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222546.